Among the major innovations of the WHO 5th edition is the definition of MDS with low blast count and SF3B1 mutations, which has been incorporated into the former category of MDS LB with ring sideroblasts (RS) [2]. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.